Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.000 | 8.000 | 0.000 |
Stocks | 92.000 | 92.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.011 | 20.299 |
Price to Book | 3.953 | 3.045 |
Price to Sales | 2.441 | 2.613 |
Price to Cash Flow | 16.999 | 16.600 |
Dividend Yield | 1.517 | 1.427 |
5 Years Earnings Growth | 16.518 | 29.190 |
Name | Net % | Category Average |
---|---|---|
Consumer Cyclical | 16.040 | 13.347 |
Industrials | 15.890 | 8.935 |
Technology | 15.040 | 12.663 |
Energy | 12.130 | 7.157 |
Communication Services | 9.920 | 4.423 |
Utilities | 9.280 | 3.445 |
Basic Materials | 8.230 | 6.811 |
Healthcare | 6.850 | 6.376 |
Consumer Defensive | 6.620 | 7.285 |
Number of long holdings: 37
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Larsen & Toubro | INE018A01030 | 8.62 | 3,420.95 | -0.83% | |
Bharti Airtel | INE397D01024 | 8.49 | 1,640.75 | +2.52% | |
Mahindra & Mahindra | INE101A01026 | 8.17 | 2,971.45 | +1.61% | |
Reliance Industries | INE002A01018 | 8.17 | 1,253.05 | +1.42% | |
Infosys | INE009A01021 | 7.24 | 1,859.95 | -1.13% | |
NTPC | INE733E01010 | 4.77 | 323.00 | +0.54% | |
Sun Pharma | INE044A01036 | 4.38 | 1,739.10 | +0.22% | |
Tata Consultancy | INE467B01029 | 3.38 | 4,100.05 | +0.01% | |
Hindustan Unilever | INE030A01027 | 3.35 | 2,408.75 | +1.04% | |
UltraTech Cement | INE481G01011 | 3.27 | 11,479.40 | -0.57% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Life Equity Fund 3 | 27.23B | 11.99 | 12.12 | 11.14 | ||
Reliance Life Equity Fund 2 | 3.32B | 10.75 | 11.25 | 11.37 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review